Back to shop

Parteck® ODT





Parteck® ODT excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is a directly compressible excipient designed for orally disintegrating tablets and provides rapid disintegration and exceptional strength as well as a pleasant taste and mouthfeel. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.

Parteck® ODT – Directly Compressible Excipient for ODTs

Orally disintegrating tablets (ODTs) are preferred for their convenience and speed. By providing fast-acting medication, ODTs allow manufacturers to add value to existing compounds and – important for competitive standing – extend product life cycles. With the ODT market growing at around 20% per year, the opportunities are considerable. Merck’s Parteck® ODT gives formulators the opportunity to produce top quality, rapid acting tablets more cost effectively than ever.

Benefits of Parteck® ODT:

  • Robust tablets at low compression forces
  • Rapid disintegration and dissolution
  • No license payments
  • High dilution potential – up to 50% load of your active pharmaceutical ingredient (API)
  • Tablets with Parteck® ODT are suitable for conventional coating
  • Emprove® documentation and regulatory support

Additional information


Merck KGaA

Quantity 1

100 gr


DC Excipient, Direct compression

Dosage Form

ODT, orally disintegrating tablets, Tablets

Documents and Links

Safety Data Sheet for Parteck® ODT 100490